½ÃÀ庸°í¼­
»óǰÄÚµå
1594536

ÇÙÀÇÇÐ À̹Ì¡ Àåºñ ½ÃÀå : Á¦Ç°, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Nuclear Imaging Equipment Market by Product (PET Imaging Systems, Planar Scintigraphy Imaging Systems, SPECT Imaging Systems), Application (Cardiology, Neurology, Oncology), End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 187 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÇÙÀÇÇÐ À̹Ì¡ Àåºñ ½ÃÀåÀº 2023³â¿¡ 29¾ï 8,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2024³â¿¡´Â 31¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 7.39%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 49¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÇÙÀÇÇÐ À̹Ì¡ Àåºñ´Â PET, SPECT, ÇÏÀ̺긮µå À̹Ì¡ ½Ã½ºÅÛ µî ü³» »ý¸®ÇÐÀû °úÁ¤À» ½Ã°¢È­ÇÏ´Â ±â¼ú·Î ±¸¼ºµÇ¸ç, ½ÉÀåÇÐ, Á¾¾çÇÐ, ½Å°æÇÐ µîÀÇ ºÐ¾ß¿¡¼­ Áø´Ü, º´±â °áÁ¤ ¹× Ä¡·á ¸ð´ÏÅ͸µ¿¡ ÇʼöÀûÀÎ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÅøÀÇ Çʿ伺Àº Á¶±â Áø´ÜÀ» µ½°í ¸ÂÃãÇü ÀǷḦ ÃËÁøÇÏ´Â Á¤È®ÇÏ°í ºñħ½ÀÀûÀÎ À̹Ì¡À» Á¦°øÇÏ´Â ´É·Â¿¡ ÀÖ½À´Ï´Ù. ÃÖÁ¾ »ç¿ëó´Â º´¿ø, ¿µ»ó Áø´Ü¼¾ÅÍ, ¿¬±¸ ±â°ü µî ´Ù¾çÇϸç, ¸¸¼ºÁúȯ Áõ°¡¿Í ³ëÀÎ Àα¸ Áõ°¡°¡ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ¿µ»ó ±â¼úÀÇ ¹ßÀü, Áúº´ Á¶±â ¹ß°ßÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, Àü ¼¼°è ÀÇ·á ÁöÃâ Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. ½ÅÈï ½ÃÀå¿¡¼­´Â ÀÇ·á ÀÎÇÁ¶óÀÇ °³¼±°ú ÀÌ·¯ÇÑ ±â¼úÀÇ Ã¤ÅÃÀÌ È®´ëµÊ¿¡ µû¶ó Å« ºñÁî´Ï½º ±âȸ°¡ ÀÖ½À´Ï´Ù. À̹ÌÁö ºÐ¼® °­È­¸¦ À§ÇÑ AI ÅëÇÕ ¹× »õ·Î¿î ¹æ»ç¼º ÃßÀûÀÚ °³¹ß°ú °°Àº Çõ½ÅÀº °æÀï ¿ìÀ§¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ³ôÀº Àåºñ ºñ¿ë, ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, ¹æ»ç¼º ÀǾàǰ ºÎÁ· °¡´É¼º µî ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ºñ¿ë È¿À²ÀûÀÎ À̹Ì¡ ¼Ö·ç¼ÇÀ» °³¹ßÇϰí Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ÅëÇØ ½ÃÀå ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â ±âȸ°¡ ÀÖ½À´Ï´Ù. ±â¼ú Çõ½Å¿¡ °¡Àå ÀûÇÕÇÑ ºÐ¾ß´Â À̹ÌÁö ÇØ»óµµ¿Í Á¤È®µµ Çâ»ó, ¹æ»ç¼± ÇÇÆø °¨¼Ò, ¸ÖƼ¸ð´Þ À̹Ì¡ ¼Ö·ç¼ÇÀÇ ÅëÇÕÀÔ´Ï´Ù. Àü¹ÝÀûÀ¸·Î ÇÙÀÇÇÐ À̹Ì¡ ½ÃÀåÀÇ Æ¯¼ºÀº º¸´Ù Áøº¸ÀûÀ̸鼭µµ Á¢±ÙÇϱ⠽¬¿î ±â¼ú·Î ÁøÈ­Çϰí ÀÖÀ¸¸ç, ÀÌ´Â Áö¼ÓÀûÀÎ R&D ÅõÀÚÀÇ Çʿ伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù. ±â¾÷Àº ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿ÍÀÇ Çù·Â¿¡ ÁýÁßÇÏ¿© ¿µ»ó Áø´ÜÀÇ È¿À²¼º°ú ȯÀÚ °á°ú¸¦ ÃÖÀûÈ­ÇÔÀ¸·Î½á ´Ù¾çÇÑ ¼¼°è ½ÃÀå¿¡¼­ ¹Ì°³Ã´µÈ ÀáÀç·ÂÀ» È®º¸ÇØ¾ß ÇÕ´Ï´Ù. ¶Ç ´Ù¸¥ °úÁ¦´Â ½Ã½Ã°¢°¢ º¯È­ÇÏ´Â ÇöÁö ±ÔÁ¦ ±âÁØÀ» ÁؼöÇÏ´Â °ÍÀ¸·Î, ¹ÎøÇϰí ÀûÀÀ·Â ÀÖ´Â Àü·«ÀÌ ÇÊ¿äÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ[2023³â] 29¾ï 8,000¸¸ ´Þ·¯
¿¹Ãø³â[2024³â] 31¾ï 9,000¸¸ ´Þ·¯
¿¹Ãø³â[2030³â] 49¾ï 1,000¸¸ ´Þ·¯
CAGR(%) 7.39%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ÇÙÀÇÇÐ À̹Ì¡ Àåºñ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®¸¦ °ø°³ÇÕ´Ï´Ù.

ÇÙÀÇÇÐ À̹Ì¡ Àåºñ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«Àû ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¿ªÀû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • °í·ÉÀÚ ±ÞÁõ°ú ÀÌ¿¡ µû¸¥ °ü·Ã Áúȯ Áõ°¡
    • µ¥ÀÌÅÍ ÅëÇÕ À̹Ì¡ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
    • ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù.
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¿µ»ó Áø´Ü ½Ã½ºÅÛÀÇ ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • ÇÙÀÇÇÐ À̹Ì¡ ÀåºñÀÇ ±â¼úÀû Áøº¸
    • ¿µ»ó Áø´Ü¼¾ÅÍ Çö´ëÈ­¸¦ À§ÇÑ ¹Î°£ ¹× °ø°ø ÅõÀÚ
    • ½ÅÈï ±¹°¡¿¡¼­ÀÇ ³ôÀº ¼ºÀå ±âȸ
  • ½ÃÀå °úÁ¦
    • º´¿ø ¿¹»ê »è°¨¿¡ ´ëÇÑ ¿ì·Á

Porter's Five Forces: ÇÙÀÇÇÐ ¿µ»ó±â±â ½ÃÀå °ø·«À» À§ÇÑ Àü·«Àû Åø

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â µ¥ Áß¿äÇÑ ÅøÀÔ´Ï´Ù. PorterÀÇ Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀïÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ¸ð»öÇϱâ À§ÇÑ ¸íÈ®ÇÑ ¹æ¹ýÀ» ¼³¸íÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» º¸¿ÏÇϸç ÀáÀçÀû µµÀüÀ» ÇÇÇÔÀ¸·Î½á º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÇÙÀÇÇÐ À̹Ì¡ Àåºñ ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÇÙÀÇÇÐ À̹Ì¡ Àåºñ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ ´ã°í ÀÖÀ¸¸ç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀ̰í Àû±ØÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ÇÙÀÇÇÐ ¿µ»óÀåºñ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

ÇÙÀÇÇÐ À̹Ì¡ Àåºñ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ¼¼ºÐÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÏ¿© °ø±Þ¾÷ü°¡ Ä¡¿­ÇÑ °æÀï¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º: ÇÙÀÇÇÐ À̹Ì¡ Àåºñ ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÇÙÀÇÇÐ À̹Ì¡ Àåºñ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ: ÇÙÀÇÇÐ À̹Ì¡ Àåºñ ½ÃÀå¿¡¼­ ¼º°øÀ¸·Î °¡´Â ±æ Â÷Æ®

ÇÙÀÇÇÐ À̹Ì¡ Àåºñ ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÎ¹®¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ½ÃÀå ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÎ¹®ÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ±â¼úÇϰí ÀÖ½À´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, »ê¾÷ÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÔ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ÇÙÀÇÇÐ À̹Ì¡ Àåºñ ½ÃÀå : Á¦Ç°º°

  • ¼­·Ð
  • PET À̹Ì¡ ½Ã½ºÅÛ
  • Æò¸é ½ÅƼ±×¶óÇÇ ¿µ»ó ½Ã½ºÅÛ
  • SPECT À̹Ì¡ ½Ã½ºÅÛ
    • ÇÏÀ̺긮µå SPECT À̹Ì¡ ½Ã½ºÅÛ
    • ½ºÅĵå¾ó·Ð SPECT À̹Ì¡ ½Ã½ºÅÛ

Á¦7Àå ÇÙÀÇÇÐ À̹Ì¡ Àåºñ ½ÃÀå : ¿ëµµº°

  • ¼­·Ð
  • ½ÉÀ庴ÇÐ
  • ½Å°æÇÐ
  • Á¾¾çÇÐ

Á¦8Àå ÇÙÀÇÇÐ À̹Ì¡ Àåºñ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼­·Ð
  • Çмú¿¬±¸ ¼¾ÅÍ
  • º´¿ø
  • ¿µ»ó ¼¾ÅÍ

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ÇÙÀÇÇÐ À̹Ì¡ Àåºñ ½ÃÀå

  • ¼­·Ð
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÇÙÀÇÇÐ À̹Ì¡ Àåºñ ½ÃÀå

  • ¼­·Ð
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÇÙÀÇÇÐ À̹Ì¡ Àåºñ ½ÃÀå

  • ¼­·Ð
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

¾ð±ÞµÈ ±â¾÷

  • Absolute Imaging Inc.
  • Ashby Gorman Baker Ltd.
  • BCL X-Ray Canada Inc.
  • Canon Medical Systems Corporation
  • CMR Naviscan Corporation
  • DDD-Diagnostic A/S
  • Digirad Corporation
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Mediso Ltd.
  • MILabs B.V.
  • MR Solutions Ltd.
  • PerkinElmer Inc.
  • Shimadzu Corporation
  • Siemens Healthineers AG
KSA 24.11.29

The Nuclear Imaging Equipment Market was valued at USD 2.98 billion in 2023, expected to reach USD 3.19 billion in 2024, and is projected to grow at a CAGR of 7.39%, to USD 4.91 billion by 2030.

Nuclear imaging equipment comprises technologies such as PET, SPECT, and hybrid imaging systems that visualize physiological processes within the body, crucial in diagnosing, staging, and treatment monitoring across fields like cardiology, oncology, and neurology. The necessity of these tools lies in their ability to offer precise and non-invasive imaging which aids in early diagnosis and facilitates personalized medicine. The end-use scope spans hospitals, diagnostic imaging centers, and research institutions, with notable growth driven by rising incidences of chronic diseases and the growing elderly population. Key factors influencing market growth include advancements in imaging technologies, increasing awareness of early disease detection's advantages, and heightened healthcare expenditure worldwide. There is a substantial opportunity in emerging markets due to improving healthcare infrastructure and the expanding adoption of these technologies. Innovations such as AI integration for enhanced image analysis and the development of novel radiotracers can offer competitive advantages. However, market growth faces challenges from high equipment costs, stringent regulatory requirements, and possible shortages of radiopharmaceuticals. There are opportunities for businesses to develop cost-effective imaging solutions and engage in strategic partnerships to broaden their market presence. The best areas for innovation revolve around enhancing imaging resolution and precision, reducing exposure to radiation, and integrating multi-modal imaging solutions. Overall, the nature of the nuclear imaging market is evolving towards more sophisticated, yet accessible technologies, highlighting a need for continuous R&D investments. Companies should focus on collaborations with healthcare providers to optimize imaging efficiency and patient outcomes, thus capturing untapped potential in the diverse global market. A further challenge is ensuring compliance with ever-evolving regional regulatory norms, necessitating agile and adaptable strategies.

KEY MARKET STATISTICS
Base Year [2023] USD 2.98 billion
Estimated Year [2024] USD 3.19 billion
Forecast Year [2030] USD 4.91 billion
CAGR (%) 7.39%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Nuclear Imaging Equipment Market

The Nuclear Imaging Equipment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rapidly growing geriatric population and the subsequent increase in the prevalence of associated diseases
    • Growing demand for data integrated imaging systems
    • Rapidly increasing focus on personalized medicine
  • Market Restraints
    • High cost of diagnostic imaging systems
  • Market Opportunities
    • Technological advancement in the nuclear imaging equipment
    • Private and public investments to modernize the diagnostic imaging centers
    • High growth opportunities in emerging countries
  • Market Challenges
    • Concerns regarding hospital budget cuts

Porter's Five Forces: A Strategic Tool for Navigating the Nuclear Imaging Equipment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Nuclear Imaging Equipment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Nuclear Imaging Equipment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Nuclear Imaging Equipment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Nuclear Imaging Equipment Market

A detailed market share analysis in the Nuclear Imaging Equipment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Nuclear Imaging Equipment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Nuclear Imaging Equipment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Nuclear Imaging Equipment Market

A strategic analysis of the Nuclear Imaging Equipment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Nuclear Imaging Equipment Market, highlighting leading vendors and their innovative profiles. These include Absolute Imaging Inc., Ashby Gorman Baker Ltd., BCL X-Ray Canada Inc., Canon Medical Systems Corporation, CMR Naviscan Corporation, DDD-Diagnostic A/S, Digirad Corporation, GE Healthcare, Koninklijke Philips N.V., Mediso Ltd., MILabs B.V., MR Solutions Ltd., PerkinElmer Inc., Shimadzu Corporation, and Siemens Healthineers AG.

Market Segmentation & Coverage

This research report categorizes the Nuclear Imaging Equipment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across PET Imaging Systems, Planar Scintigraphy Imaging Systems, and SPECT Imaging Systems. The SPECT Imaging Systems is further studied across Hybrid SPECT Imaging Systems and Standalone SPECT Imaging Systems.
  • Based on Application, market is studied across Cardiology, Neurology, and Oncology.
  • Based on End-User, market is studied across Academic & Research Centers, Hospitals, and Imaging Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rapidly growing geriatric population and the subsequent increase in the prevalence of associated diseases
      • 5.1.1.2. Growing demand for data integrated imaging systems
      • 5.1.1.3. Rapidly increasing focus on personalized medicine
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of diagnostic imaging systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in the nuclear imaging equipment
      • 5.1.3.2. Private and public investments to modernize the diagnostic imaging centers
      • 5.1.3.3. High growth opportunities in emerging countries
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding hospital budget cuts
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Nuclear Imaging Equipment Market, by Product

  • 6.1. Introduction
  • 6.2. PET Imaging Systems
  • 6.3. Planar Scintigraphy Imaging Systems
  • 6.4. SPECT Imaging Systems
    • 6.4.1. Hybrid SPECT Imaging Systems
    • 6.4.2. Standalone SPECT Imaging Systems

7. Nuclear Imaging Equipment Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiology
  • 7.3. Neurology
  • 7.4. Oncology

8. Nuclear Imaging Equipment Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Research Centers
  • 8.3. Hospitals
  • 8.4. Imaging Centers

9. Americas Nuclear Imaging Equipment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Nuclear Imaging Equipment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Nuclear Imaging Equipment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Absolute Imaging Inc.
  • 2. Ashby Gorman Baker Ltd.
  • 3. BCL X-Ray Canada Inc.
  • 4. Canon Medical Systems Corporation
  • 5. CMR Naviscan Corporation
  • 6. DDD-Diagnostic A/S
  • 7. Digirad Corporation
  • 8. GE Healthcare
  • 9. Koninklijke Philips N.V.
  • 10. Mediso Ltd.
  • 11. MILabs B.V.
  • 12. MR Solutions Ltd.
  • 13. PerkinElmer Inc.
  • 14. Shimadzu Corporation
  • 15. Siemens Healthineers AG
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦